January 28, 2004
New York Times highlights McClellan's leadership at FDA
CHP/PCOR in the news: New York Times on January 25, 2004Under the leadership of commissioner Mark McClellan, currently on leave as a core faculty member of CHP/PCOR, the U.S. Food and Drug Administration has taken some bold steps that have surprised observers, who expected the agency to avoid controversial issues and make pro-business decisions. This New York Times article discusses McClellan?s approach at the FDA and examines some recent agency decisions, such as banning ephedra and allowing over-the-counter sales of emergency birth control. The article includes comment from CHP/PCOR director Alan Garber.
Read more »



About CISAC
Mailing List
@StanfordCISAC
Facebook